Hedge Fund - VenBio Select Advisor
Apellis Pharmaceuticals Inc. (APLS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $211,566,663 | 3.71% | 12,222,222 | $18.51 |
| 2 | 2025 - Q1 (2025-03-31) | $267,299,995 | 4.17% | 12,222,222 | $27.63 |
| 3 | 2024 - Q4 (2024-12-31) | $390,011,104 | 5.51% | 12,222,222 | $30.07 |
| 4 | 2024 - Q3 (2024-09-30) | $320,444,441 | 4.67% | 11,111,111 | $37.03 |
| 5 | 2024 - Q2 (2024-06-30) | $426,222,218 | 5.67% | 11,111,111 | $45.29 |
| 6 | 2024 - Q1 (2024-03-31) | $653,111,105 | 7.61% | 11,111,111 | $63.75 |
| 7 | 2023 - Q4 (2023-12-31) | $665,111,104 | 9.18% | 11,111,111 | $50.73 |
| 8 | 2023 - Q3 (2023-09-30) | $422,666,662 | 6.59% | 11,111,111 | $43.93 |
| 9 | 2023 - Q2 (2023-06-30) | $1,012,222,212 | 13.73% | 11,111,111 | $86.28 |
| 10 | 2023 - Q1 (2023-03-31) | $732,888,882 | 10.86% | 11,111,111 | $57.70 |
| 11 | 2022 - Q4 (2022-12-31) | $549,418,750 | 8.21% | 10,625,000 | $53.04 |
| 12 | 2022 - Q3 (2022-09-30) | $691,538,000 | 12.77% | 10,125,000 | $59.17 |
| 13 | 2022 - Q2 (2022-06-30) | $443,382,000 | 8.76% | 9,805,000 | $45.59 |
| 14 | 2022 - Q1 (2022-03-31) | $480,155,000 | 8.76% | 9,450,000 | $44.15 |
| 15 | 2021 - Q4 (2021-12-31) | $404,507,000 | 6.88% | 8,555,555 | $39.37 |
| 16 | 2021 - Q3 (2021-09-30) | $164,800,000 | 2.58% | 5,000,000 | $56.19 |
| 17 | 2021 - Q2 (2021-06-30) | $63,531,000 | 1.1% | 1,005,230 | $51.60 |
| 18 | 2021 - Q1 (2021-03-31) | $42,910,000 | 0.74% | 1,000,000 | $47.32 |
| 19 | 2018 - Q2 (2018-06-30) | $0 | 0% | 0 | $22.98 |
| 20 | 2018 - Q1 (2018-03-31) | $7,454,000 | 0.35% | 396,635 | $19.65 |
| 21 | 2017 - Q4 (2017-12-31) | $7,316,000 | 0.47% | 396,635 | $14.72 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center